The Serbian private healthcare sector – including private healthcare providers and pharmacies – has been on a steady incline over the past several years. BDK Advokati Senior Partner Vladimir Dasic, Prica & Partners Partner Tijana Lalic, and Karanovic & Partners Senior Partner Marjan Poljak take a deep dive into what makes the sector tick and grow.
Clifford Chance, Dentons, and Rymarz Zdort Maruta Advise on Sale of American Heart of Poland
Clifford Chance has advised AHP Investments on the sale of a majority stake in the American Heart of Poland medical network to Gruppo San Donato in partnership with GKSD. Dentons advised the target. Rymarz Zdort Maruta advised the buyers.
Gide Advises Farmaceutici Procemsa on Acquisition of Master Pharm
Gide has advised Investindustrial portfolio company Farmaceutici Procemsa on its acquisition of a majority stake in Poland's Master Pharm.
SSK&W and Tau Nowacki Advise on Medi Ventures' Investment in Pogaduszki
SSK&W has advised Medi Ventures on its investment in speech therapy start-up Pogaduszki. Tau Nowacki advised Pogaduszki.
BDV Advises Provectus Capital Partners on Dragas Dental Design Acquisition
BDV has advised private equity fund Provectus Capital Partners – the majority stakeholder of the Adria Dental Group – on the acquisition of Dragas Dental Design.
SSK&W Advises Medi Ventures on Virtual Monitor Investment
SSK&W has advised VC fund Medi Ventures on its investment in clinical trial platform Virtual Monitor.
B2RLaw and DZP Advise on Vinci HiTech Fund Investment into Oasis Diagnostics
B2RLaw has advised the Vinci HiTech ASI fund on its nearly PLN 14 million investment into Polish medical technology start-up Oasis Diagnostics. Domanski Zakrzewski Palinka advised Oasis Diagnostics.